Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Efficacy of a Swab Transport System in Maintaining Viability of Neisseria gonorrhoeae andStreptococcus pneumoniae

Shaker E. Farhat, Mary Thibault, Roslyn Devlin
Shaker E. Farhat
Department of Microbiology, St. Michael's Hospital, Toronto, Ontario M4Y 1J6, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Thibault
Department of Microbiology, St. Michael's Hospital, Toronto, Ontario M4Y 1J6, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roslyn Devlin
Department of Microbiology, St. Michael's Hospital, Toronto, Ontario M4Y 1J6, and
University of Toronto, Toronto, Ontario M5G 1L5, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.8.2958-2960.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The efficacy of swab transport systems in maintaining viability ofNeisseria gonorrhoeae and Streptococcus pneumoniae is crucial both for establishing definitive diagnosis and for monitoring emerging resistance. We tested the efficacy of a newly modified Amies charcoal swab transport system, the StarSwab SP131X (Starplex Scientific, Inc., Etobicoke, Ontario, Canada), by using a combined total of 31 clinical and American Type Culture Collection stock reference strains of N. gonorrhoeae andS. pneumoniae in 46 suspensions of concentrations ranging from 105 to 108 CFU/ml. Triplicate swabs per strain held at room temperature for 0, 24, and 48 h were plated without prior vortexing, and their growths were graded. All 31 strains were viable at 0 and 24 h. Gonococcal viability at 48 h varied considerably, even among strains with comparable inoculum sizes, suggesting that viability might be strain dependent and confirming the different structural and growth profiles of gonococcal strains.S. pneumoniae strains showed consistent viability, with all strains recovered at all holding periods. This study demonstrates that the StarSwab SP131X is capable of maintaining the viability of N. gonorrhoeae and S. pneumoniae for at least 24 and 48 h, respectively, and reinforces the need for adequate sampling and for timely processing of specimens to maintain optimum performance.

One of the crucial steps for effective laboratory diagnosis of infection is adequate collection and transport of specimens for culture. For years, swabs have been used to sample and transport clinical material obtained from infected sites for microbiological examination. While swab systems are considered less optimal than direct plating for culturing purposes, they have become increasingly important in view of the delay of specimen transport necessitated by recent strategies of cost containment and consolidation of laboratory services. As a result, there have been continuous efforts to improve and assess the efficacies of swab systems and to develop industry-wide standards to monitor their performances (1, 6, 7, 12, 13, 16, 18; C. Hetchler, C. Brown, and J. C. Galbraith, Abstr. 100th Gen. Meet. Am. Soc. Microbiol., abstr. C-152, p. 164, 2000).

Among the key factors impacting the efficacy of a swab system is its ability to maintain viability of fastidious organisms for sufficient duration. In the present study, we tested the efficacy of the newly modified StarSwab SP131X (Starplex Scientific, Inc., Etobicoke, Ontario, Canada) with two fastidious organisms, Neisseria gonorrhoeae and Streptococcus pneumoniae. Both organisms are significant pathogens, commonly encountered in clinical specimens and known for their fragile viability. We opted to examine the Amies charcoal-enriched rather than charcoal-free StarSwab, because of the former's common usage as a multipurpose swab in many clinical facilities, owing to the ability of the added charcoal to neutralize toxic materials (7, 17). During the initial part of this study, it was noted that while all of the pneumococcal strains exhibited consistent viability profiles, the five gonococcal strains in the study exhibited significant differences in colonial morphology and growth yield at various intervals. As a result, we extended the gonococcal portion of the study with an additional 20 clinical strains, with the purpose of obtaining more objective and reliable data to assess the efficacy of this swab transport system.

(Results of this work were previously presented in part at the 100th General Meeting of the American Society for Microbiology, Los Angeles, Calif., 21 to 25 May 2000 [S. E. Farhat, M. Thibault, and S. J. Finn, Abstr. 100th Gen. Meet. Am. Soc. Microbiol., abstr. C-156, p. 164, 2000].)

A total of 31 clinical and reference isolates were used in this study, including 25 N. gonorrhoeae and 6 S. pneumoniaestrains, as listed in Tables 2 and 3, respectively. The clinical strains were isolated from patient specimens and were identified by standard methods (8, 14). The stock reference strains belonged to the American Type Culture Collection (ATCC) and were obtained from lyophilized pellets (Kwik-Stik; MicroBiologics, Inc., St. Cloud, Minn.) or freeze-dried cultures (Cryocults; Quality Technologies, Newbury Park, Calif.). Each strain was subcultured three times prior to testing to ensure its purity and stability. Suspensions of test organisms were initially prepared to a concentration equivalent to a McFarland no. 1 standard, which was diluted with Trypticase soy broth (TSB; PML Microbiologicals, Mississauga, Ontario, Canada) to yield final concentrations of 108, 107, 106, or 105 CFU/ml, as assigned for each strain. Briefly, 1 ml of the 108-CFU/ml suspension (at a McFarland no. 1 standard, diluted 1:3) was added to 9 ml of TSB to yield a 107-CFU/ml concentration. Serial 10-fold dilutions were prepared to yield 106- and 105-CFU/ml concentrations. A portion of the 105-CFU/ml suspension was further diluted 1:100 to obtain a 103-CFU/ml concentration. Reference plates were prepared in duplicate by plating 0.1 ml of the 103-CFU/ml suspension onto chocolate agar plates (PML Microbiologicals) for the N. gonorrhoeae strains and 5% Columbia sheep blood agar plates (PML Microbiologicals) for theS. pneumoniae strains, by using the spread plate technique to obtain colony counts and determine inoculum size (18). The inoculum size was calculated by multiplying the average number of colonies recovered on the reference plates by the dilution factor used. The swabs were inoculated with the assigned strains at the predetermined concentration. Each swab was removed from its device and dipped into 0.1 ml of the suspension for 3 to 4 s to allow adsorption and then returned to its transport device. Triplicate swabs per strain, held at room temperature for 0, 24, and 48 h, were plated without prior vortexing, to simulate the regular laboratory practice of swab processing. Although vortexing of swabs has been advocated on the basis that it enhances the recovery of entrapped bacteria (11, 19), most clinical laboratories do not vortex swabs prior to inoculation of culture media, nor is swab vortexing indicated in the procedure according to the manufacturers' instructions. The S. pneumoniae and N. gonorrhoeae plates were streaked and incubated in 5% CO2 at 36°C and were read at 36 and 48 h, respectively. Growth obtained from each of the cultured swabs was graded according to criteria adapted from Thompson and French (18). Briefly, a score of between 0 and 5 was assigned to each plate based on the amount and distribution of colonies within the plate's four quadrants (Table 1). The average yield score for each triplicate set (average growth score [AGS]) was calculated as a measure of the organism viability at the test interval.

View this table:
  • View inline
  • View popup
Table 1.

Criteria for evaluation of growth obtained from cultured swabs

We compared bacterial yields of reference versus clinical strains by using AGSs of suspensions prepared at the same concentrations to determine whether the type of strain influenced viability in the StarSwab. The mean AGS was calculated for both reference and clinical types (data not shown). We found that in general both strain types had equivalent viability. The effects of duration of swab storage and of inoculum size on organism viability were also studied (Tables 2 and3). Although allS. pneumoniae strains were recovered at all holding periods regardless of inoculum size, prolonged storage at ambient temperature reduced the yield of N. gonorrhoeae, a phenomenon universally observed (1, 18). As early as 1954, Stuart and his colleagues had remarked that “Over 24 hours, the viability of gonococci deteriorates progressively.” (17). Later studies also showed that prolonged transport adversely affected gonococcal recovery (9). In our hands, gonococcal viability was obtained in all strains at 24 h, confirming the adequacy of swab performance for at least 24 h from the time of sampling. Viability was still recoverable at 48 h in strains with inoculum sizes greater than 1.4 × 106 CFU/ml, but as can be seen from the results in Table 2, inoculum size was not the sole factor impacting gonococcal recovery. There were strains of equivalent inoculum sizes that displayed different yields. For example, two different strains of N. gonorrhoeae, one clinical (no. 21, Table 2) and the other a reference strain (ATCC 19424, Table 2), both with an inoculum size of 1.4 × 106 CFU/ml, were both recovered at 24 h, but only one remained viable at 48 h. In strains with lower inocula, 48-h viability was obtained with some strains with an inoculum size as low as 0.6 × 105CFU/ml, but not with others at even higher inocula. There was no consistency in yield within this group, suggesting that viability in some strains was strain dependent and not only contingent on the number of colonies on the swab, an observation noted by other investigators (1). While a few recent investigations of swab transport systems had tested a minimal number of gonococcal strains, often with a single strain (usually an ATCC strain), to study efficacy (6, 7, 12, 13; Hetchler et al., Abstr. 100th Gen. Meet. Am. Soc. Microbiol., 2000), the use of multiple clinical strains has been recommended as a more accurate marker of swab performance (18). What induces gonococcal heterogeneity is not clear, but several recent studies have suggested that strains of N. gonorrhoeae possess diverse structural and growth profiles, which may explain their antigenic and physiologic diversity. It is known that the surfaces of N. gonorrhoeae strains display a highly variable antigenic structure, such as that of pilin expression (2, 15). In addition, growth patterns within certain serogroups as well as structural differences among typed strains, based on sequenced genes encoding protein products responsible for serovar specificity, have been identified (5, 10). Characterization of gonococcal strains also demonstrated strain differences based on auxotyping, serotyping, plasmid profiling, and DNA amplification fingerprinting (3).

View this table:
  • View inline
  • View popup
Table 2.

Recovery of Neisseria gonorrhoeae strains in various concentrations at different holding periods

View this table:
  • View inline
  • View popup
Table 3.

Recovery of Streptococcus pneumoniae strains in two concentrations at different holding periods

Recent studies of the Amies StarSwab have shown variable recovery ofN. gonorrhoeae at different holding periods, with questionable performance at 24 and 48 h when compared to other products (1, 6, 18; Hetchler et al., Abstr. 100th Gen. Meet. Am. Soc. Microbiol., 2000). The results we have presented here refer to the improved Amies charcoal StarSwab product. While the swab rayon tips are made of nonbacteriostatic fibers to allow adequate absorption of organisms from the sample, the ample fibrous material may have contributed to organism entanglement and reduced release. Reduction or loss of recovery has been previously attributed to organism entrapment, particularly if the number of entrapped organisms was too low to be adequately expressed once the swab was applied to the culture medium (4, 16).

In summary, we have conducted an efficacy study to test the ability of a commercially available swab transport system to maintain viability ofN. gonorrhoeae and S. pneumoniae. While viability of some N. gonorrhoeae isolates may be strain dependent, this study has demonstrated that the newly modified Amies charcoal StarSwab is capable of maintaining viability of N. gonorrhoeae and S. pneumoniae for at least 24 and 48 h, respectively, and reinforces the need for adequate sampling and for timely processing of specimens to maintain optimum performance.

ACKNOWLEDGMENTS

This work was supported in part by Starplex Scientific, Inc.

We thank the Public Health Laboratories of the Ontario Ministry of Health for kindly providing four of the gonococcal clinical strains used in this study.

FOOTNOTES

    • Received 26 February 2001.
    • Returned for modification 28 March 2001.
    • Accepted 30 May 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Arbique J. C.,
    2. Forward K. R.,
    3. LeBlanc J.
    Evaluation of four commercial transport media for the survival of Neisseria gonorrhoeae.Diagn. Microbiol. Infect. Dis.362000163168
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Backman M.,
    2. Kallstrom H.,
    3. Jonsson A. B.
    The phase-variable pilus-associated protein PilC is commonly expressed in clinical isolates of Neisseria gonorrhoeae, and shows sequence variability among strains.Microbiology1441998149156
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Camarena J. J.,
    2. Nogueira J. M.,
    3. Dasi M. A.,
    4. Moreno F.,
    5. Garcia R.,
    6. Ledesma E.,
    7. Llorca J.,
    8. Hernandez J.
    DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains.Sex. Transm. Dis.221995128136
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Collee J. G.,
    2. Watt B.,
    3. Brown R.,
    4. Johnstone S.
    The recovery of anaerobic bacteria from swabs.J. Hyg.721974339347
    OpenUrl
  5. 5.↵
    1. Cooke S. J.,
    2. Jolley K.,
    3. Ison C. A.,
    4. Young H.,
    5. Heckels J. E.
    Naturally occurring isolates of Neisseria gonorrhoeae, which display anomalous serovar properties, express PIA/PIB hybrid porins, deletions in PIB or novel PIA molecules.FEMS Microbiol. Lett.16219987582
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Hindiyeh M.,
    2. Acevedo V.,
    3. Carroll K. C.
    Comparison of three transport systems (Starplex StarSwab II, the new Copan Vi-Pak Amies agar gel collection and transport swabs, and BBL Port-A-Cul) for maintenance of anaerobic and fastidious aerobic organisms.J. Clin. Microbiol.392001377380
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Human R. P.,
    2. Jones G. A.
    Survival of bacteria in swab transport packs.Med. Lab. Sci.4319861418
    OpenUrlPubMed
  8. 8.↵
    1. Knapp J. S.,
    2. Koumans E. H.
    Neisseria and Branhamella Manual of clinical microbiology 7th ed. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. 1999 586 603 American Society for Microbiology Washington, D.C.
  9. 9.↵
    1. Monif G. R.,
    2. Jordan P. A.,
    3. Thompson J. L.,
    4. Shaara R.
    Pragmatic factors influencing the detection of Neisseria gonorrhoeae.Obstet. Gynecol.591982649652
    OpenUrlPubMed
  10. 10.↵
    1. Moyes A.,
    2. Young H.
    Typing of Neisseria gonorrhoeae by auxotype, serovar and lectin agglutination.Br. J. Biomed. Sci.501993295300
    OpenUrlPubMed
  11. 11.↵
    1. Perry J. L.
    Factors influencing transfer of bacteria from collection and transport systems to culture media.Clin. Lab. Sci.21989340341
    OpenUrl
  12. 12.↵
    1. Perry J. L.
    Assessment of swab transport systems for aerobic and anaerobic organism recovery.J. Clin. Microbiol.35199712691271
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Roelofsen E.,
    2. van Leeuwen M.,
    3. Meijer-Severs G. J.,
    4. Wilkinson M. H. F.,
    5. Degener J. E.
    Evaluation of the effects of storage in two different swab fabrics and under three different transport conditions on recovery of aerobic and anaerobic bacteria.J. Clin. Microbiol.37199930413043
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Ruoff K. L.,
    2. Whiley R. A.,
    3. Beighton D.
    Streptococcus Manual of clinical microbiology 7th ed. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. 1999 283 296 American Society for Microbiology Washington, D.C.
  15. 15.↵
    1. Serkin C. D.,
    2. Seifert H. S.
    Frequency of pilin antigenic variation in Neisseria gonorrhoeae.J. Bacteriol.180199819551958
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Sng E.-H.,
    2. Rajan V. S.,
    3. Yeo K.-L.,
    4. Goh A.-J.
    The recovery of Neisseria gonorrhoeae from clinical specimens: effects of different temperatures, transport times, and media.Sex. Transm. Dis.919827478
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Stuart R. D.,
    2. Toshach S. R.,
    3. Patsula T. M.
    The problem of transport of specimens for culture of gonococci.Can. J. Public Health4519547383
    OpenUrlPubMed
  18. 18.↵
    1. Thompson D. S.,
    2. French S. A.
    Comparison of commercial Amies transport systems with in-house Amies medium for recovery of Neisseria gonorrhoeae.J. Clin. Microbiol.37199930203021
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Yrios J. W.,
    2. Balish E.,
    3. Helstad A.,
    4. Field C.,
    5. Inhorn S.
    Survival of anaerobic and aerobic bacteria on cotton swabs in three transport systems.J. Clin. Microbiol.11975196200
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Efficacy of a Swab Transport System in Maintaining Viability of Neisseria gonorrhoeae andStreptococcus pneumoniae
Shaker E. Farhat, Mary Thibault, Roslyn Devlin
Journal of Clinical Microbiology Aug 2001, 39 (8) 2958-2960; DOI: 10.1128/JCM.39.8.2958-2960.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of a Swab Transport System in Maintaining Viability of Neisseria gonorrhoeae andStreptococcus pneumoniae
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy of a Swab Transport System in Maintaining Viability of Neisseria gonorrhoeae andStreptococcus pneumoniae
Shaker E. Farhat, Mary Thibault, Roslyn Devlin
Journal of Clinical Microbiology Aug 2001, 39 (8) 2958-2960; DOI: 10.1128/JCM.39.8.2958-2960.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

gonorrhea
Neisseria gonorrhoeae
Pneumococcal Infections
Specimen Handling
Streptococcus pneumoniae

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X